|
|
|
w.t. small GTPase RhoA, NM_001664
|
|
|
|
|
|
|
RhoA-T19N, dominant Negative mutant
|
|
|
|
|
|
|
RhoA-V14, constitutive active mutant
|
|
|
|
| |
|
|
|
|
|
|
|
|
w.t. small GTPase Rac, NM_006908
|
|
|
|
|
|
|
Rac-T17N, dominant negative mutant
|
|
|
|
| |
|
|
|
|
|
|
|
|
w.t small GTPase CDC42, NM_001791
|
|
|
|
|
|
|
CDC42-T17N, dominant negative mutant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
∆MEKK1(KM), dominant negative mutant
|
|
|
|
| |
|
|
|
|
|
|
|
|
w.t. TAK1, also as MAP3K8
|
|
|
|
|
|
|
TAK1 K63W kinase dead DN mutant
|
|
|
|
|
|
|
|
|
|
|
|
|
MEK1 S218/222E constitutive activate mutant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GSK3b KM dominant negative mutant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|